HCID 54075037, compound → HCID 67693362, compound

HRID 1763863Notes

Reaction equation

HRID 1763863 reaction equation
[O:1]([C:8]1[CH:9]=[CH:10][C:11]2[CH2:12][C@H:13]3[N:24](C(OCC(Cl)(Cl)[Cl:30])=O)[CH2:23][CH2:22][C@@:19]4([C:20]=2[CH:21]=1)[C@H:14]3[CH2:15][CH2:16][CH2:17][CH2:18]4)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1>C(O)(=O)C.[Zn]>[ClH:30].[O:1]([C:8]1[CH:9]=[CH:10][C:11]2[CH2:12][C@H:13]3[NH:24][CH2:23][CH2:22][C@@:19]4([C:20]=2[CH:21]=1)[C@H:14]3[CH2:15][CH2:16][CH2:17][CH2:18]4)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1

Participants

4

Procedure

To a solution of 3.4 g (0.007 mol) of (-)-3-phenoxy-N-trichlorocarbethoxymorphinan in 40 ml of 90% acetic acid was added portionwise 2.0 g of zinc-dust. The mixture was stirred at room temperature for 16 hours and filtered. The filtrate was concentrated in vacuo and the residue was partitioned between ether and dilute ammonium hydroxide. The ether solution was extracted with 4 N hydrochloric acid. The acidic solution was extracted with chloroform. After removal of chloroform, the crude hydrochloride was crystallized from ethanol to afford 0.7 g (29%) of (-)-3-phenoxymorphinan hydrochloride, mp 322°-324°, [α]25D -33.88° (c 1.00, MeOH).

Workup

  1. filtrationfiltered
  2. concentrationThe filtrate was concentrated in vacuo
  3. customthe residue was partitioned between ether and dilute ammonium hydroxide
  4. extractionThe ether solution was extracted with 4 N hydrochloric acid
  5. extractionThe acidic solution was extracted with chloroform
  6. customAfter removal of chloroform
  7. customthe crude hydrochloride was crystallized from ethanol

Sources & evidence

ORD record
ord-bab96c437baa4ba9a86902ce92c244a4
Source dataset
uspto-grants-1978_09
Patent number
US04113729

Reaction notes

Loading…